Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Ana Espirito Santo"'
Autor:
Ana Espirito Santo, Sergio Chacim, Luis Leite, Isabel Cristina, Claudia Moreira, Dulcineia Pereira, Margarida Dantas, Marta Nunes, Luisa Viterbo, Angelo Martins, Ilidia Moreira, Isabel Oliveira, Nelson Domingues, Jose Mario Mariz, Rui Medeiros
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 1 (2014)
BackgroundAcute MyeloidLeukemia is a clonal malignant disease, whit disappointing cure rates withcurrent treatment options. The authors’ intent to characterise acute myeloidleukaemia patients and to evaluate the outcome gain associated with the use
Externí odkaz:
https://doaj.org/article/61207fc73e494a019fcb9235cbeeec25
Autor:
Jose Mario Mariz, Teresa Ribeiro, Ana Rita Marques, Ana Espirito-Santo, Clara Castro, Márcio Tavares, Cláudia Moreira, Gonçalo Cordeiro Ferreira
Publikováno v:
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 40:281-286
Purpose To investigate the prognostic value of interim PET (PETi) in adult HL patients, comparing visual with semiquantitative analysis. Material and methods Retrospective analysis of Hodgkin's lymphoma (HL) patients diagnosed between 2012 and 2016 i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efd442c503fecb5d6fc71d3f4953e4f4
https://doi.org/10.1016/j.remnie.2020.06.016
https://doi.org/10.1016/j.remnie.2020.06.016
Autor:
Márcio Tavares, Ana Espirito-Santo, Jose Mario Mariz, Teresa Ribeiro, Gonçalo Cordeiro Ferreira, Cláudia Moreira, Clara Castro, Ana Rita Marques
Publikováno v:
Revista Española de Medicina Nuclear e Imagen Molecular. 40:281-286
Resumen Objetivo Investigar el valor pronostico de la tomografia por emision de positrones (PET) interim (PETi) en pacientes adultos con linfoma de Hodgkin (LH), comparando el analisis visual con el semicuantitativo. Material y metodos Analisis retro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ef8dccf278a87be2b224c0f5ecd3851
https://doi.org/10.1016/j.remn.2020.06.022
https://doi.org/10.1016/j.remn.2020.06.022
Autor:
Rui Henrique, Ana Espirito-Santo, Isabel Oliveira, Ângelo Martins, Sérgio Chacim, Maria Eduarda Couto, Nelson Luís de Campos Domingues, Dulcineia Pereira, Cláudia Moreira, Jose Mario Mariz, Luisa Viterbo, Ilídia Moreira
Publikováno v:
Indian Journal of Hematology & Blood Transfusion
Gastric diffuse large B cell lymphoma (DLBCL) represents the majority of all gastric lymphomas. We report a series of gastric DLBCL diagnosed and treated in a single center, between 2010 and 2018 (included). We retrospectively analyzed the population
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebd75428f6d49fdb7eff8d61caac1302
https://doi.org/10.1007/s12288-020-01391-9
https://doi.org/10.1007/s12288-020-01391-9
Autor:
Luisa Viterbo, Ana Espirito Santo, Rui Henrique, Dulcineia Pereira, Jose Mario Mariz, Nelson Luís de Campos Domingues, Cláudia Moreira, Maria Eduarda Couto, Ângelo Martins, Sérgio Chacim, Ilídia Moreira, Isabel Oliveira
Publikováno v:
Indian J Hematol Blood Transfus
Gastric mucosa-associated lymphoid tissue non-Hodgkin lymphoma (gMALT NHL) is the second most common gastrointestinal lymphoma (50% of all gastric lymphomas), being closely associated with Helicobacter pylori infection, justifying that antibiotic the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62c8a84cbc70b87e52edea04b2586611
https://europepmc.org/articles/PMC9209548/
https://europepmc.org/articles/PMC9209548/
Autor:
Isabel Oliveira, Ângelo Martins, Susana Lisboa, Cecília Correia, Joana Vieira, Susana Bizarro, Sérgio Chacim, Nuno Cerveira, Rui Santos, Cláudia Moreira, Bruno Loureiro, Lurdes Torres, Jose Mario Mariz, Dulcineia Pereira, Nelson Luís de Campos Domingues, Luisa Viterbo, Ilídia Moreira, Manuel R. Teixeira, Ana Espirito-Santo
Publikováno v:
BMC Cancer
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Background Most patients with chronic myeloid leukemia (CML) treated with tyrosine kinase inhibitors (TKIs) will relapse if treatment is withdrawn, but various trials have recently demonstrated that a significant proportion of patients who achieved a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::313757ab65fee2156faca9c998256570
http://europepmc.org/articles/PMC6292043
http://europepmc.org/articles/PMC6292043
Autor:
Isabel Oliveira, Jose Mario Mariz, Nelson Domingues, Cláudia Moreira, Maria Luisa Viterbo, Ângelo Martins, Dulcineia Pereira, Sérgio Chacim, Maria Ilidia Moreira, Miguel Quintela, Ana Espirito Santo, Iolanda Vieira
Publikováno v:
Blood. 134:5356-5356
Introdution Optimal treatment of young patients with high-risk diffuse large B-cell lymphoma (DLBCL) remains a matter of debate. With the addition of rituximab, response rates (RR) and overall survival (OS) have improved significantly, but the best t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50e8048419aa4b425ab1fe0277237347
https://doi.org/10.1182/blood-2019-131254
https://doi.org/10.1182/blood-2019-131254
Autor:
Ana Espirito Santo, Dulcineia Pereira, Jose Mario Mariz, Isabel Oliveira, Cláudia Moreira, Miguel Quintela, Iolanda Vieira, Nelson Domingues, Ângelo Martins, Maria Luisa Viterbo, Maria Ilidia Moreira, Sérgio Chacim
Publikováno v:
Blood. 134:5342-5342
Introduction: The incidence of central nervous system (CNS) relapse in diffuse large B-cell lymphoma (DLBCL) is approximately 5%. Although the introduction of rituximab for the treatment of DLBCL has reduced the risk of CNS relapse, the median overal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4032e2dd72851361fe36259ec62c6c7f
https://doi.org/10.1182/blood-2019-130993
https://doi.org/10.1182/blood-2019-130993
Autor:
Ana Espirito Santo, Rui Medeiros
Publikováno v:
Expert Opinion on Drug Metabolism & Toxicology. 9:1625-1634
Chemotherapy is the current standard treatment for hematological malignancies for both curative and palliative purposes. Unfortunately, in the current treatment scenario chemotherapy resistance is an issue that is know to lead to a relapse in cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10538edfab763b092ac6d33dac3c21f0
https://doi.org/10.1517/17425255.2013.835803
https://doi.org/10.1517/17425255.2013.835803
Autor:
Ana Maria Meireles, Leonardo Moço, Catarina Campos Costa, Dulcineia Pereira, Sérgio Chacim, Nelson Domingues, Ana Espírito Santo, Isabel Oliveira, Ângelo Martins, Ilídia Moreira, Luísa Viterbo, Gil Brás, Cláudia Moreira, Mário Mariz
Publikováno v:
HemaSphere, Vol 7, p e81356dd (2023)
Externí odkaz:
https://doaj.org/article/ca480e71bc09443499635b2261538394